{
  "ptid_time": "002_S_0729_2010-07-22",
  "img_path": "/data/qiuhui/data/adni/images/002_S_0729/2010-07-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 23,337 mm³, 4.5% above the reference mean. With a Z-score of 0.11 (54.5th percentile), this represents normal volume ; whole brain volume measures 862,436 mm³, 16.2% below the reference mean. With a Z-score of -2.02 (2.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 69.1 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Renal-Genitourinary. MMSE: 24.0. MoCA: 20.0. Logical Memory: 1.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.46 SUVR (significant elevated); Amyloid beta: 601.70 pg/mL (mild reduced); Total tau: 338.80 pg/mL (mild elevated); Phosphorylated tau: 32.70 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant whole brain atrophy (Z-score -2.02, 2.2nd percentile) alongside mildly reduced Aβ, mildly elevated tau, and significantly elevated AV45 (amyloid PET), suggesting amyloid pathology and neurodegeneration. Cognitive scores (MMSE 24, MoCA 20) are below normal, consistent with cognitive impairment but not severe enough for dementia.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology given biomarker profile).  \n\n**Confidence:** **High** (supported by structural atrophy, amyloid/tau biomarkers, and intermediate cognitive scores).",
  "timestamp": "2025-07-25T20:05:25.939483"
}